For 23 years, IRETA has hosted medical students for the Scaife Medical Student Fellowship in Substance Use Disorders. The program has been held virtually since 2020, due to COVID-19. This year’s program continued online. For three weeks in both June and July, small cohorts of medical and pharmacy students logged in from across the country […]
Addiction
Will the FDA’s Crackdown on Tobacco Products Help Improve Public Health?
Is a Juul ban enough to solve the problem of nicotine addiction in young adults? Time has shown us that bans often don’t keep people from using a product or substance.
How Can We Better Serve Transgender and Gender Non-Conforming Individuals in Addiction Treatment Settings?
Despite that fact that transgender and gender non-conforming people disproportionately experience substance use and mental health disorders, there is a lack of trans-inclusive care and knowledge about gender identity within the addiction treatment field.
Happy National Nurses Week from IRETA
This week is National Nurses Week. We would like to take this opportunity to thank the nurses who work specifically in the field of substance use disorder treatment.
The Role of Alcohol in the Overdose Crisis
Much of the recent discourse in the addiction treatment and recovery community has touched upon the record-breaking rise in overdose deaths in the United States, as well as the sharp uptick in alcohol use that came about at the beginning of the COVID-19 pandemic. But very rarely is alcohol discussed as being a part of […]
The Importance of Speaking the Same Language in Addiction Treatment
There is a recognizable need for improved treatment for substance use disorder in the United States. Drug overdose deaths are at an all-time high and standardization of the delivery and coverage for addiction treatment can be hard to find. Unfortunately, as it stands, addiction treatment and reimbursement practices can vary greatly from state to state, […]
Women Are Drinking More Than Ever. Many May Not Be Aware How It Is Affecting Their Health.
Women have increased their heavy drinking days by 41%. The pandemic is partly to blame, but the problem didn’t start there.
Opportunity Out of Crisis: A Natural Experiment
The COVID-19 pandemic has presented challenges and opportunities for substance disorder treatment. IRETA and Vital Strategies are studying effects of OTP rule changes.
Skyrocketing Methamphetamine Overdose Deaths Show Our “Crisis Response” Must Expand Beyond Just Opioids
The National Institutes of Health (NIH) released a study that shows a combination of two medications, injectable naltrexone and oral bupropion, is safe and effective in treating methamphetamine use disorder.
A New Service Delivery Model: How IRETA has Adapted Clinical Quality Improvement in the Era of COVID
IRETA faced the challenge of switching completely to telehealth with very little notice. IRETA’s Director of Clinical Quality Improvement Services, David Reazin, MHS, answered questions about what it was like to adapt to telehealth and the pros and cons of virtual groups.
